Literature DB >> 12422059

Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate.

Vikram K Yeragani1, Steven Roose, Mallika Mallavarapu, R K A Radhakrishna, Vanessa Pesce.   

Abstract

Depression is associated with increased cardiovascular mortality in patients with preexisting cardiac illness. A decrease in cardiac vagal function as suggested by a decrease in heart rate variability (HRV) or heart period variability has been linked to sudden death in patients with cardiac disease as well as in normal controls. Recent studies have shown decreased vagal function in cardiac patients with depression as well as in depressed patients without cardiac illness. In this study, we compared 20 h awake and sleep heart period nonlinear measures using quantification of nonlinearity and chaos in two groups of patients with major depression and ischemic heart disease (mean age 59-60 years) before and after 6 weeks of treatment with paroxetine or nortriptyline. Patients received paroxetine, 20-30 mg/day or nortriptyline targeted to 190-570 nmol/l for 6 weeks. For HRV analysis, 24 patients were included in the paroxetine treatment study and 20 patients in the nortriptyline study who had at least 20000 s of awake data. The ages of these groups were 60.4 +/- 10.5 years for paroxetine and 60.8 +/- 13.4 years for nortriptyline. There was a significant decrease in the largest Lyapunov exponent (LLE) after treatment with nortriptyline but not paroxetine. There were also significant decreases in nonlinearity scores on S(netPR) and S(netGS) after nortriptyline, which may be due to a decrease in cardiac vagal modulation of HRV. S(netGS) and awake LLE were the most significant variables that contributed to the discrimination of postparoxetine and postnortriptyline groups even with the inclusion of time and frequency domain measures. These findings suggest that nortriptyline decreases the measures of chaos probably through its stronger vagolytic effects on cardiac autonomic function compared with paroxetine, which is in agreement with previous clinical and preclinical reports. Nortriptyline was also associated with a significant decrease in nonlinearity scores, which may be due to anticholinergic and/or sympatholytic effects. As depression is associated with a strong risk factor for cardiovascular mortality, one should be careful about using any drug that adversely affects cardiac vagal function. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12422059     DOI: 10.1159/000066390

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  10 in total

1.  Age alters cardiac autonomic modulations during and following exercise-induced heat stress in females.

Authors:  Anthony S Leicht; Andreas D Flouris; Antonia Kaltsatou; Andrew J Seely; Christophe L Herry; Heather E Wright Beatty; Glen P Kenny
Journal:  Temperature (Austin)       Date:  2018-03-15

2.  A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Authors:  I H Richard; M P McDermott; R Kurlan; J M Lyness; P G Como; N Pearson; S A Factor; J Juncos; C Serrano Ramos; M Brodsky; C Manning; L Marsh; L Shulman; H H Fernandez; K J Black; M Panisset; C W Christine; W Jiang; C Singer; S Horn; R Pfeiffer; D Rottenberg; J Slevin; L Elmer; D Press; H C Hyson; W McDonald
Journal:  Neurology       Date:  2012-04-11       Impact factor: 9.910

Review 3.  Psychological and pharmacological interventions for depression in patients with coronary artery disease.

Authors:  Phillip J Tully; Ser Yee Ang; Emily Jl Lee; Eileen Bendig; Natalie Bauereiß; Jürgen Bengel; Harald Baumeister
Journal:  Cochrane Database Syst Rev       Date:  2021-12-15

Review 4.  Stress, depression, and coronary artery disease: modeling comorbidity in female primates.

Authors:  Carol A Shively; Dominique L Musselman; Stephanie L Willard
Journal:  Neurosci Biobehav Rev       Date:  2008-06-24       Impact factor: 8.989

Review 5.  Depression and apathy in Parkinson's disease.

Authors:  Irene Hegeman Richard
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

Review 6.  Psychological and pharmacological interventions for depression in patients with coronary artery disease.

Authors:  Harald Baumeister; Nico Hutter; Jürgen Bengel
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

7.  Wide spectrum of inhibitory effects of sertraline on cardiac ion channels.

Authors:  Hyang-Ae Lee; Ki-Suk Kim; Sung-Ae Hyun; Sung-Gurl Park; Sung Joon Kim
Journal:  Korean J Physiol Pharmacol       Date:  2012-10-18       Impact factor: 2.016

8.  Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review.

Authors:  Louis T van Zyl; Takuya Hasegawa; Katsutaro Nagata
Journal:  Biopsychosoc Med       Date:  2008-06-30

9.  Treatment of affective disorders in cardiac disease.

Authors:  Nicole Mavrides; Charles B Nemeroff
Journal:  Dialogues Clin Neurosci       Date:  2015-06       Impact factor: 5.986

10.  Comparative Study of Heart Rate Variability in Patients with Schizophrenia, Bipolar Disorder, Post-traumatic Stress Disorder, or Major Depressive Disorder.

Authors:  Eunok Moon; Seung-Hwan Lee; Do-Hyung Kim; Boram Hwang
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-12-24       Impact factor: 2.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.